病例报告

1例甲巯咪唑乳膏治疗口服不耐受的甲状腺功能亢进症病例报道

  • 徐婷 ,
  • 张豫文
展开
  • 1.上海交通大学医学院附属瑞金医院药剂科,上海 200025
    2.上海交通大学医学院附属瑞金医院内分泌代谢病科,上海 200025
徐 婷(1986—),女,主管药师,硕士;电子信箱:xt40859@rjh.com.cn
张豫文,电子信箱:bfzyw@163.com

收稿日期: 2023-09-18

  录用日期: 2024-03-04

  网络出版日期: 2024-03-28

基金资助

嘉定区卫生健康委员会课题(2020-jdyxzdzk-01);上海交通大学医学院附属瑞金医院课题(2017XK02)

A case report of hyperthyroidism with intolerance of oral medication with methimazole cream

  • Ting XU ,
  • Yuwen ZHANG
Expand
  • 1.Department of Pharmacy, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
    2.Department of Endocrine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
ZHANG Yuwen, E-mail: bfzyw@163.com.

Received date: 2023-09-18

  Accepted date: 2024-03-04

  Online published: 2024-03-28

Supported by

Project of Jiading District Health Commission(2020-jdyxzdzk-01);Project of Ruijin Hospital, Shanghai Jiao Tong University School of Medicine(2017XK02)

摘要

患者老年男性,因“甲巯咪唑口服不耐受,已行放射性碘治疗6月”就诊,存在甲状腺功能亢进症疗效与不良反应的矛盾,结合患者意愿,临床采用甲巯咪唑乳膏局部外用的治疗方案。12周的随诊中,患者症状明显缓解,甲状腺功能明显改善,且血常规和肝功能未出现明显异常。该病例在用药选择上打破常规思维,结合药物效应动力学、药物代谢动力学理论基础和医师临床经验摸索制定甲巯咪唑乳膏初始量和减药量,亦为此制剂用药提供临床参考意见。

本文引用格式

徐婷 , 张豫文 . 1例甲巯咪唑乳膏治疗口服不耐受的甲状腺功能亢进症病例报道[J]. 上海交通大学学报(医学版), 2024 , 44(3) : 412 -416 . DOI: 10.3969/j.issn.1674-8115.2024.03.016

Abstract

An elderly male patient sought medical attention due to "intolerance of methimazole tablet and radioiodine treatment for six months". There was a contradiction between the efficacy and adverse drug reaction. Based on the patient′s wishes, the clinical treatment of methimazole cream was adopted. During the follow-up of 12 weeks, the patient′s symptoms were significantly improved, the indicators of thyroid function declined to normal level, and there were no significant abnormalities in indicators for routine blood test and liver function. The case broke away from conventions in medication selection, showing that the initial and reduced dosage was explored and formulated by combination of the theoretical basis of pharmacodynamics, pharmacokinetics and physician′s clinical experience. It also provided clinical reference for the use of the topical formulation.

参考文献

1 中华医学会内分泌学分会, 中国医师协会内分泌代谢科医师分会,中华医学会核医学分会, 等. 中国甲状腺功能亢进症和其他原因所致甲状腺毒症诊治指南[J]. 中华内分泌代谢杂志, 2022, 38(8): 700-748.
1 Chinese Society of Endocrinology, Chinese Endocrinologist Association, Chinese Society of Nuclear Medicine, et al. Guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis[J]. Chinese Journal of Endocrinology and Metabolism, 2022, 38(8): 700-748.
2 TAKATA K, KUBOTA S, FUKATA S, et al. Methimazole-induced agranulocytosis in patients with Graves′ disease is more frequent with an initial dose of 30 mg daily than with 15 mg daily[J]. Thyroid, 2009, 19(6): 559-563.
3 赵维娟, 杨永革, 张梅, 等. 甲巯咪唑乳膏透皮吸收的体内动力学[J]. 中国医院药学杂志, 1999, 19(12): 714-716.
3 ZHAO W J, YANG Y G, ZHANG M, et al. Study of pharmacokinetics for percutanous absorption of thiamazole ointment in rabbits[J]. Chinese Journal of Hospital Pharmacy, 1999, 19(12): 714-716.
4 柳晓泉, 耿芳, 王松磊, 等. 甲巯咪唑大鼠经皮给药的药代动力学[J]. 中国药科大学学报, 2005, 36(4): 342-345.
4 LIU X Q, GE F, WANG S L, et al. Study of pharmacokinetics for percutanous absorption of methimazole in rats[J]. Journal of China Pharmaceutical University, 2005, 36(4): 342-345.
5 沈隽, 刘红, 朱禧星. 甲巯咪唑软膏治疗甲状腺机能亢进症的临床验证[C]//中华医学会第六次全国内分泌学术会议论文汇编. 广州:中华医学会, 2002: 348-349.
5 SHEN J, LIU H, ZHU X X. Clinical validation of methimazole cream in the treatment of hyperthyroidism[C]//A compilation of papers the 6th National Endocrine Academic Conference of the Chinese Medical Association. Guangzhou, China: Chinese Medical Association, 2002: 348-349.
6 石勇铨, 刘志民, 顾明君, 等. 甲巯咪唑软膏治疗Graves病疗效和安全性的初步结果[J]. 第二军医大学学报, 2002, 23(3): 346-347.
6 SHI Y Q, LIU Z M, GU M J, et al. Preliminary results on the efficacy and safety of methimazole cream in the treatment of hyperthyroidism caused by Graves′ disease [J]. Former Academic Journal of Second Military Medical University, 2002, 23(3): 346-347.
7 黄国良, 张闿珍, 佘耀远, 等. 他巴唑剂量与其甲状腺内浓度的关系[J]. 中华医学杂志, 1991, 71(6): 301-306.
7 HUANG G L, ZHANG K Z, SHE Y Y, et al. The relationship between the dose of methimazole and its intrathyroid concentration in patients with hyperthyroidism caused by Graves′ disease[J]. National Medical Journal of China, 1991, 71(6): 301-306.
8 NAKAMURA H, NOH J Y, ITOH K, et al. Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves′ disease[J]. J Clin Endocrinol Metab, 2007, 92(6): 2157-2162.
9 ROSS D S, BURCH H B, COOPER D S, et al. 2016 American thyroid association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis[J]. Thyroid, 2016, 26(10): 1343-1421.
文章导航

/